Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | G6PD | P11413 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2831267 | 0.91 | ALDH1A1 (0.58) | ALDH1A1CYP3A4MAPTTDP1MEN1 | |
| SCHEMBL2521402 | 0.89 | ALDH1A1 (0.52) | ALDH1A1CYP3A4MAPTTDP1MEN1 | |
| SCHEMBL11671332 | 0.88 | ALDH1A1 (0.42) | ALDH1A1CYP3A4MAPTTDP1MEN1 | |
| SCHEMBL1758439 | 0.84 | ALDH1A1 (0.48) | ALDH1A1CYP3A4MAPTTDP1MEN1 | |
| SCHEMBL11670044 | 0.84 | ALDH1A1 (0.50) | ALDH1A1CYP3A4MAPTTDP1MEN1 | |
| SCHEMBL3366894 | 0.79 | ALDH1A1 (0.50) | ALDH1A1CYP3A4MAPTTDP1MEN1 | |
| SCHEMBL1828689 | 0.79 | TSHR (0.48) | ALDH1A1CYP3A4MAPTTDP1MEN1 | |
| SCHEMBL1758269 | 0.79 | GPR35 (0.52) | ALDH1A1CYP3A4MAPTTDP1MEN1 | |
| SCHEMBL11695958 | 0.79 | GPR35 (0.50) | ALDH1A1CYP3A4MAPTTDP1MEN1 | |
| SCHEMBL9483397 | 0.79 | MAPT (0.55) | ALDH1A1CYP3A4MAPTTDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260110607-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES WITH MINIMIZED FALSE POSITIVES | ALTI LLC (US) | 2026-04-23 | — | — | US | claimed |
| US-12517047-B2 | Transport and detection of explosive samples | ALTI LLC (US) | 2026-01-06 | — | — | US | claimed |
| US-20250237601-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES | ALTI LLC | 2025-07-24 | — | — | US | claimed |
| CN-118832582-A | Multi-mechanical-arm cooperation track prediction method based on mixed time steps | 台州学院 | 2024-10-25 | — | — | CN | claimed |
| CN-118585240-B | Automatic optimization method for performance of operating system | 麒麟软件有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118585240-A | Automatic optimization method for performance of operating system | 麒麟软件有限公司 | 2024-09-03 | — | — | CN | claimed |
| CN-117061795-A | System and method for adaptively refreshing EDID of channel interface along with resolution of display window | 深圳市嘉利达专显科技有限公司 | 2023-11-14 | — | — | CN | claimed |
| US-20120291931-A1 | COMPOSITE COMPOUND INCLUDING EXPLOSIVE AND MODIFIER FOR EXPLOSIVE AND METHOD OF MANUFACTURE THEREOF | MCDERMOTT WILL & EMERY | 2012-11-22 | — | — | US | claimed |
| US-20100096050-A1 | MODIFIER FOR EXPLOSIVES | LIMITED LIABILITY COMPANY IFO | 2010-04-22 | — | — | US | claimed |
| EP-2128117-A2 | MODIFIER FOR EXPLOSIVES | Obshestvo S Ogranichennoy Otvetstvennjctyu "Ifokhim" (RU) | 2009-12-02 | — | — | EP | claimed |
| CN-121949417-A | Selective phosphorus acyl synthesis method | 武汉工程大学 | 2026-05-01 | — | — | CN | disclosed |
| US-20260110607-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES WITH MINIMIZED FALSE POSITIVES | ALTI LLC (US) | 2026-04-23 | — | — | US | disclosed |
| WO-2026059315-A1 | IMAGE ENCODING/DECODING METHOD AND DEVICE, AND RECORDING MEDIUM ON WHICH BITSTREAM IS STORED | 엘지전자 주식회사 | 2026-03-19 | — | — | WO | disclosed |
| WO-2026010357-A1 | IMAGE ENCODING/DECODING METHOD AND DEVICE, AND RECORDING MEDIUM ON WHICH BITSTREAM IS STORED | 엘지전자 주식회사 | 2026-01-08 | — | — | WO | disclosed |
| US-12517047-B2 | Transport and detection of explosive samples | ALTI LLC (US) | 2026-01-06 | — | — | US | disclosed |
| US-5524545-A | Process and apparatus for photolytic degradation of explosives | GLOBAL ENVIRONMENTAL SOLUTIONS, INC. (US) | 1996-06-11 | — | — | US | disclosed |
| US-5516970-A | Process and apparatus for photolytic degradation of explosives | GLOBAL ENVIRONMENTAL SOLUTIONS, INC. (US) | 1996-05-14 | — | — | US | disclosed |
| US-5370845-A | Dissolving explosives in organic solvents, irradiating with ultraviolet light | ALLIANT TECHSYSTEMS (US) | 1994-12-06 | — | — | US | disclosed |
| US-4348958-A | Projectile having impact responsive initiator means | SYSTEMS, SCIENCE AND SOFTWARE (US) | 1982-09-14 | — | — | US | disclosed |
| US-4011265-A | 3,3\"-Diamino- or 3,3\"-dimethoxy-octanitro-m-terphenyl | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1977-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260110607-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES WITH MINIMIZED FALSE POSITIVES | TES, TNPO1, SLC2A1 | ALDH1A1 4406/4885CYP3A4 4388/4885MAPT 1861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.